Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 70, Issue 6, 2011, Pages 1025-1032

  Toms, Tracey E ^a,b   Panoulas, Vasileios F ^a   Smith, Jacqueline P ^a   Douglas, Karen M J ^a   Metsios, Giorgos S ^a,c   Stavropoulos Kalinoglou, Antonios ^a,c   Kitas, George D ^a,b  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN A; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; COMPLEMENT COMPONENT C5; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DR ANTIGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RHEUMATOID FACTOR; STAT4 PROTEIN; STATIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SMOKING;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HLA-DRB1 CHAINS; HUMANS; LIPIDS; MALE; MIDDLE AGED; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; STAT4 TRANSCRIPTION FACTOR; TNF RECEPTOR-ASSOCIATED FACTOR 1;

EID: 79955828781     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.144634     Document Type: Article

References (39)

1. Symmons D, Turner G, Webb R, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) 2002 ; 41 : 793-800. (Pubitemid 34822963) (Pubitemid 34822963)
2. Reilly PA, Cosh JA, Maddison PJ, et al. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis 1990 ; 49 : 363-9. (Pubitemid 20170512) (Pubitemid 20170512)
3. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953 ; 249 : 553-6.
4. Panoulas VF, Douglas KM, Milionis HJ, et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 2007 ; 46 : 1477-82. (Pubitemid 47317098) (Pubitemid 47317098)
5. Toms TE, Symmons DP, Kitas GD. Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol 2010 ; 8 : 301-26.
6. Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, et al. Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 2009 ; 68 : 242-5.
7. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, et al. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil 2009 ; 16 : 188-94.
8. Stevens RJ, Douglas KM, Saratzis AN, et al. Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med 2005 ; 7 : 1-24.
9. Toms TE, Panoulas VF, Douglas KM, et al. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipidassociated cardiovascular risk? Ann Rheum Dis 2010 ; 69 : 683-8.
10. Vaughan JH, Kouri T, Petersen J, et al. On the etiology of rheumatoid arthritis. Scand J Rheumatol Suppl 1988 ; 74 : 19-28. (Pubitemid 19124869) (Pubitemid 19124869)
11. Silman AJ, MacGregor AJ, Thomson W, et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993; 32 : 903-7. (Pubitemid 23301303) (Pubitemid 23301303)
12. Seldin MF, Amos CI, Ward R, et al. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999 ; 42 : 1071-9. (Pubitemid 29268942) (Pubitemid 29268942)
13. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987 ; 30 : 1205-13. (Pubitemid 18005792) (Pubitemid 18005792)
14. Newton JL, Harney SM, Wordsworth BP, et al. A review of the MHC genetics of rheumatoid arthritis. Genes Immun 2004 ; 5 : 151-7. (Pubitemid 38967646) (Pubitemid 38967646)
15. Orozco G, Barton A. Update on the genetic risk factors for rheumatoid arthritis. Expert Rev Clin Immunol 2010 ; 6 : 61-75.
16. Michou L, Lasbleiz S, Rat AC, et al. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci U S A 2007 ; 104 : 1649-54. (Pubitemid 46214645) (Pubitemid 46214645)
17. Orozco G, Alizadeh BZ, Delgado-Vega AM, et al. Association of STAT4 with rheumatoid arthritis: a replication study in three European populations. Arthritis Rheum 2008 ; 58 : 1974-80. (Pubitemid 351988089) (Pubitemid 351988089)
18. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 2007 ; 357 : 1199-209. (Pubitemid 47443179) (Pubitemid 47443179)
19. Farragher TM, Goodson NJ, Naseem H, et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 2008 ; 58 : 359-69. (Pubitemid 351294870) (Pubitemid 351294870)
20. Farragher TM, Plant D, Flynn E, et al. Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients. Arthritis Care Res (Hoboken) 2010 ; 62 : 676-82.
21. Myasoedova E, Crowson CS, Kremers HM, et al. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 2010 ; 69 : 1310-14.
22. van Halm VP, Nielen MM, Nurmohamed MT, et al. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 2007 ; 66 : 184-8. (Pubitemid 46226052) (Pubitemid 46226052)
23. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 ; 31 : 315-24. (Pubitemid 18091653) (Pubitemid 18091653)
24. Prevoo ML, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995 ; 38 : 44-8.
25. Kirwan JR, Reeback JS. Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986 ; 25 : 206-9. (Pubitemid 16033804) (Pubitemid 16033804)
26. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 ; 28 : 412-19. (Pubitemid 15018832) (Pubitemid 15018832)
27. Fujifilm Corporation. Automated nucleic acid exraction - QuickGene-810. 2006. http://www.autogen.com/Products/QuickGene810.htm (accessed June 2007 ).
28. Panoulas VF, Douglas KM, Smith JP, et al. Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. Endothelium 2008 ; 15 : 203-12.
29. Executive Summary of the third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 ; 285 : 2486-97.
30. Bowes J, Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 2008 ; 47 : 399-402.
31. Goodson NJ, Silman AJ, Pattison DJ, et al. Traditional cardiovascular risk factors measured prior to the onset of inflammatory polyarthritis. Rheumatology (Oxford) 2004 ; 43 : 731-6. (Pubitemid 38807430) (Pubitemid 38807430)
32. Mattey D L, Thomson W, Ollier WE, et al. Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study. Arthritis Rheum 2007 ; 56 : 1408-16. (Pubitemid 46764067) (Pubitemid 46764067)
33. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, et al. HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003 ; 114 : 647-52. (Pubitemid 36703233) (Pubitemid 36703233)
34. van Nies JA, Marques RB, Trompet S, et al. TRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies. Arthritis Res Ther 2010 ; 12 : R38.
35. Panoulas VF, Smith JP, Nightingale P, et al. Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis. Arthritis Rheum 2009 ; 60 : 39-46.
36. Olsen N J, Callahan LF, Brooks RH, et al. Associations of H LA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. Am J Med 1988 ; 84 : 257-64. (Pubitemid 18067438) (Pubitemid 18067438)
37. van Zeben D, Hazes JM, Zwinderman AH, et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. Arthritis Rheum 1991 ; 34 : 822-30.
38. Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol 2010 ; 28 : 695-701.
39. Welcome Trust Case Consortium. 2007. http://www.wtcc.org (accessed June 2010 ).